Literature for argatroban (S01.217 inhibitor)

(Topics flags: S Structure, A Assay, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2016
1. Muller,J., Becher,T., Mayer,G. and Potzsch,B.
   Aptamer-based enzyme capture assay for measurement of plasma thrombin levels
   Methods Mol Biol1380, 179-189. PubMed  Europe PubMed DOI  A  I
2. Yeh,C.H., Stafford,A.R., Leslie,B.A., Fredenburgh,J.C. and Weitz,J.I.
   Dabigatran and argatroban diametrically modulate thrombin exosite function
   PLoS ONE11, e0157471-e0157471. PubMed  Europe PubMed DOI  I
2015
3. Chen,H. and Ren,Y.
   Design, synthesis, and anti-thrombotic evaluation of some novel fluorinated thrombin inhibitor derivatives
   Arch Pharm (Weinheim)348, 408-420. PubMed  Europe PubMed DOI  I
2005
4. [YEAR:1-4-2005]Lefkowitz,J.B.
   Argatroban-coupled Affi-Gel matrix for the purification of thrombin from plasma
   Biotechnol Appl Biochem42, 189-192. PubMed  Europe PubMed DOI  I
2003
5. Hua,Y., Keep,R.F., Schallert,T., Hoff,J.T. and Xi,G.
   A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model
   Acta Neurochir Suppl86, 503-506. PubMed  Europe PubMed  I
1998
6. Nilsson,T., Sjoling-Ericksson,A. and Deinum,J.
   The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin
   J Enzyme Inhib13, 11-29. PubMed  Europe PubMed  I
1992
7. [YEAR:20-8-1992]Brandstetter,H., Turk,D., Hoeffken,H.W., Grosse,D., Sturzebecher,J., Martin,P.D., Edwards,B.F. and Bode,W.
   Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics
   J Mol Biol226, 1085-1099. PubMed  Europe PubMed DOI  S  I
1990
8. [YEAR:5-10-1990]Bode,W., Turk,D. and Sturzebecher,J.
   Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-piperidine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin
   Eur J Biochem193, 175-182. PubMed  Europe PubMed DOI  S  I
1984
9. [YEAR:3-1-1984]Kikumoto,R., Tamao,Y., Tezuka,T., Tonomura,S., Hara,H., Ninomiya,K., Hijikata,A. and Okamoto,S.
   Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid
   Biochemistry23, 85-90. PubMed  Europe PubMed DOI  I
1981
10. [YEAR:30-7-1981]Okamoto,S., Hijikata,A., Kikumoto,R., Tonomura,S., Hara,H., Ninomiya,K., Maruyama,A., Sugano,M. and Tamao,Y.
    Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion
    Biochem Biophys Res Commun101, 440-446. PubMed  Europe PubMed  I